Schiff Move Free Advanced Plus MSM Review

Usually, yes — and it's the most important thing to know about this bottle. The trials that anchor the category (GAIT, the Dona crystalline-sulfate studies) used ~1,200 mg/day chondroitin. The 'Advanced' formula typically leans on the full glucosamine dose plus MSM and hyaluronic acid, with chondroitin coming in lighter. So you're really trialing a glucosamine-HCl-plus-MSM stack more than the classic 1,500/1,200 combo. That's not necessarily bad — the category evidence is mixed regardless of chondroitin dose — but if you specifically want the chondroitin at full strength, Doctor's Best (#3) or Kirkland (#2) deliver it for less.

That's Move Free's main practical selling point: it delivers the full 1,500 mg glucosamine in just 2 tablets, versus the 4 capsules the other full-dose combos require. The lighter pill load is genuinely easier to stick to for the months a real trial needs. The catch is what gets traded to make the tablets that small — the chondroitin dose. If you hate swallowing capsules and adherence is your bottleneck, the 2-tablet convenience is a legitimate reason to choose this over the 4-cap combos.

They round out the joint-comfort angle people actually buy this category for. MSM (methylsulfonylmethane) has its own modest joint-comfort signal in small trials; hyaluronic acid is a component of joint fluid and is included at a small dose for the cushioning narrative. Both are reasonable inclusions that don't interfere with anything — but treat them as supporting cast, not the headline. The core of what you're trialing is still glucosamine, and the averaged evidence for the whole combo stays modest. Don't let the 'kitchen-sink' label convince you it's more proven than glucosamine alone.

Decide by what you value. Move Free wins on convenience and brand familiarity: 2 tablets a day, available in every pharmacy in America, the most recognizable joint brand on the shelf. The cheaper full-dose combos (Kirkland #2 at ~$13/month, Doctor's Best #3) win on chondroitin dose and price — they actually deliver the 1,200 mg chondroitin the trials used, for less money. If pill-load and brand trust matter most, Move Free. If you want the full classic dose of both actives at the best price, go with Kirkland or Doctor's Best.

8-12 weeks, then make an honest keep-or-stop call. Glucosamine and the combo ingredients act slowly on cartilage maintenance, not acute pain, so the first weeks tell you nothing. If your stiffness and morning ache are meaningfully better by month 3, you're a responder — continue. If nothing has changed, you're most likely a non-responder, and the smart move is to stop. This is a cheap, safe, time-boxed trial with a real stop rule — not a supplement to take indefinitely on hope.

Very well tolerated — usually just mild GI symptoms (nausea, heartburn) at worst, and it's one of the safest joint supplements around. The standard glucosamine caveats apply: it's typically shellfish-derived, so shellfish-allergic people should look for a fermented/vegetarian source or avoid it; there's a mild interaction signal with warfarin (possible raised INR), so anticoagulated users should tell their prescriber and monitor; and diabetics should monitor blood sugar when starting, though concerns at supplement doses have largely not held up.

1. [1] Clegg 2006 (GAIT) PMID 16495392 — Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. The NIH-funded GAIT trial (~1,583 patients) found glucosamine HCl, chondroitin sulfate, and the combination were NOT significantly better than placebo for knee-OA pain overall. Only an exploratory moderate-to-severe-pain subgroup may have benefited — the reason a convenient HCl combo like Move Free is framed as a responder trial, not a proven mobility fix.
2. [2] Towheed 2005 (Cochrane) PMID 15846645 — Glucosamine therapy for treating osteoarthritis. Cochrane review: glucosamine's apparent benefit shrank in high-quality trials and concentrated in studies using patented crystalline glucosamine SULFATE. Move Free uses the weaker-evidenced HCl form, placing it a tier below the crystalline sulfate pick (#2) on form-quality.